| Market Cap | 88.94K | P/E | - | EPS this Y | - | Ern Qtrly Grth | - |
| Income | -381.3k | Forward P/E | - | EPS next Y | - | 50D Avg Chg | -60.00% |
| Sales | - | PEG | - | EPS past 5Y | - | 200D Avg Chg | -81.00% |
| Dividend | N/A | Price/Book | 0.50 | EPS next 5Y | - | 52W High Chg | -93.00% |
| Recommedations | - | Quick Ratio | 0.00 | Shares Outstanding | 104.25M | 52W Low Chg | 233.00% |
| Insider Own | - | ROA | -9.01% | Shares Float | - | Beta | -4.59 |
| Inst Own | 6.05% | ROE | -17.60% | Shares Shorted/Prior | -/- | Price | 0.00400 |
| Gross Margin | - | Profit Margin | - | Avg. Volume | 20,264 | Target Price | - |
| Oper. Margin | - | Earnings Date | - | Volume | 232,579 | Change | 0.00% |
Alternaturals, Inc. manufactures and distributes supplements and all-natural remedies that are alternatives to prescription drugs. Its products include Focamine, an all-natural focus, attention, and concentration promoter for people suffering from ADHD; and Sombium, an alternative sleep aid. The company was formerly known as Zhong Nong Yuan Fang Holdings, Inc. and changed its name to Alternaturals, Inc. in March 2022. Alternaturals, Inc. was incorporated in 1995 and is based in Reno, Nevada.
